BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25915101)

  • 1. New muscle for old hearts: engineering tissue from pluripotent stem cells.
    Martin U
    Hum Gene Ther; 2015 May; 26(5):305-11. PubMed ID: 25915101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.
    Lu TY; Lin B; Kim J; Sullivan M; Tobita K; Salama G; Yang L
    Nat Commun; 2013; 4():2307. PubMed ID: 23942048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
    Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X
    Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac tissue engineering: a clinical perspective.
    Zimmermann WH; Tiburcy M; Eschenhagen T
    Future Cardiol; 2007 Jul; 3(4):435-45. PubMed ID: 21526914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
    Oikonomopoulos A; Kitani T; Wu JC
    Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.
    Wang F; Guan J
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):784-97. PubMed ID: 20214939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
    Montgomery A; Wong A; Gabers N; Willerth SM
    Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells for cardiac repair.
    Zwi-Dantsis L; Gepstein L
    Cell Mol Life Sci; 2012 Oct; 69(19):3285-99. PubMed ID: 22960788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.
    Lalit PA; Hei DJ; Raval AN; Kamp TJ
    Circ Res; 2014 Apr; 114(8):1328-45. PubMed ID: 24723658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the use of induced pluripotent stem cells (iPSCs) for the regeneration of tracheal cartilage.
    Imaizumi M; Nomoto Y; Sato Y; Sugino T; Miyake M; Wada I; Nakamura T; Omori K
    Cell Transplant; 2013; 22(2):341-53. PubMed ID: 22863018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cardiac extracellular matrix supports myocardial lineage commitment of pluripotent stem cells.
    Oberwallner B; Brodarac A; Anić P; Šarić T; Wassilew K; Neef K; Choi YH; Stamm C
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):416-25; discussion 425. PubMed ID: 24778452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks.
    Martin U
    Front Med (Lausanne); 2017; 4():229. PubMed ID: 29312943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
    Isomi M; Sadahiro T; Ieda M
    J Cardiol; 2019 Feb; 73(2):97-101. PubMed ID: 30420106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.
    Iseoka H; Miyagawa S; Fukushima S; Saito A; Masuda S; Yajima S; Ito E; Sougawa N; Takeda M; Harada A; Lee JK; Sawa Y
    Tissue Eng Part A; 2018 Feb; 24(3-4):287-300. PubMed ID: 28498040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From pluripotency to distinct cardiomyocyte subtypes.
    David R; Franz WM
    Physiology (Bethesda); 2012 Jun; 27(3):119-29. PubMed ID: 22689787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.